Administering Bifidobacterium pseudolongum With Arsenic Trioxide Attenuates Acute Promyelocytic Leukemia in Mice by Restoring Immune Microenvironment and Intestinal Homeostasis
Objective: Arsenic trioxide (ATO) is a cornerstone of acute promyelocytic leukemia (APL) therapy but induces severe gut microbiota dysbiosis, limiting its efficacy and safety. This study investigated whether adjunctive Bifidobacterium pseudolongum (BP) could mitigate these adverse...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
IMR Press
2026-02-01
|
| Col·lecció: | Frontiers in Bioscience-Landmark |
| Matèries: | |
| Accés en línia: | https://www.imrpress.com/journal/FBL/31/2/10.31083/FBL48584 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
